|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,364.00 GBX | +1.87% |
|
+1.87% | +4.16% |
| 04:50am | AstraZeneca, Sino Biopharm Ink Up to $1.9 Billion Respiratory Drug Licensing Deal | DJ |
| 11:46pm | AstraZeneca in China experimental COPD drug deal; upfront payment $200 million | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | +1.87% | +1.87% | +4.16% | +40.58% | +65.90% | 292B |  |  | |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
